{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:02:46Z","timestamp":1785528166011,"version":"3.56.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Istanbul University Scientific Research Projects Coordination Unit","award":["TOA-2020-35780"],"award-info":[{"award-number":["TOA-2020-35780"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12485-4","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:15:59Z","timestamp":1785309359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blood-based RBBP7 and RIBC1 methylation as a candidate epigenetic biomarker for ovarian cancer epigenetic markers RBBP7 and RIBC1 in ovarian cancer"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0893-1251","authenticated-orcid":false,"given":"\u00d6zge \u015e\u00fckr\u00fco\u011flu","family":"Erdo\u011fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4417-4005","authenticated-orcid":false,"given":"Seda K\u0131l\u0131\u00e7","family":"Erciyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7923-275X","authenticated-orcid":false,"given":"Bet\u00fcl \u00c7elik","family":"Demirba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5985-070X","authenticated-orcid":false,"given":"Ahmet","family":"Din\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0631-7044","authenticated-orcid":false,"given":"Elif","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4579-7087","authenticated-orcid":false,"given":"Funda G\u00fcng\u00f6r","family":"U\u011furlucan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2271-8481","authenticated-orcid":false,"given":"Demet Akdeniz","family":"\u00d6demi\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6530-0942","authenticated-orcid":false,"given":"\u00d6zge","family":"Pasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6871-8519","authenticated-orcid":false,"given":"P\u0131nar Mualla","family":"Saip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8919-0482","authenticated-orcid":false,"given":"H\u00fclya","family":"Yaz\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8023-3223","authenticated-orcid":false,"given":"Seref Bugra","family":"Tuncer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"3","key":"12485_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"12485_CR2","doi-asserted-by":"publisher","unstructured":"Charkhchi P et al (2020) CA125 and ovarian cancer: A comprehensive review. Cancers (Basel) 12(12). https:\/\/doi.org\/10.3390\/cancers12123730","DOI":"10.3390\/cancers12123730"},{"issue":"8","key":"12485_CR3","doi-asserted-by":"publisher","first-page":"e14588","DOI":"10.1097\/md.0000000000014588","volume":"98","author":"LY Feng","year":"2019","unstructured":"Feng LY, Chen CX, Li L (2019) Hypermethylation of tumor suppressor genes is a risk factor for poor prognosis in ovarian cancer: A meta-analysis. Med (Baltim) 98(8):e14588. https:\/\/doi.org\/10.1097\/md.0000000000014588","journal-title":"Med (Baltim)"},{"issue":"1","key":"12485_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40659-021-00340-8","volume":"54","author":"L Wang","year":"2021","unstructured":"Wang L, Gao S (2021) Identification of 5-methylcytosine-related signature for predicting prognosis in ovarian cancer. Biol Res 54(1):18. https:\/\/doi.org\/10.1186\/s40659-021-00340-8","journal-title":"Biol Res"},{"issue":"4","key":"12485_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s10555-014-9513-5","volume":"33","author":"CJ Millard","year":"2014","unstructured":"Millard CJ, Fairall L, Schwabe JW (2014) Towards an understanding of the structure and function of MTA1. Cancer Metastasis Rev 33(4):857\u2013867. https:\/\/doi.org\/10.1007\/s10555-014-9513-5","journal-title":"Cancer Metastasis Rev"},{"issue":"9","key":"12485_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/gtc.12268","volume":"20","author":"H Kitamura","year":"2015","unstructured":"Kitamura H et al (2015) Identification of novel target genes specifically activated by deregulated E2F in human normal fibroblasts. Genes Cells 20(9):739\u2013757. https:\/\/doi.org\/10.1111\/gtc.12268","journal-title":"Genes Cells"},{"key":"12485_CR7","doi-asserted-by":"crossref","unstructured":"Marin TL et al (2017) AMPK promotes mitochondrial biogenesis and function by phosphorylating the epigenetic factors DNMT1, RBBP7, and HAT1. Sci Signal 10(464) doi:ARTN eaaf747810.1126\/scisignal.aaf7478","DOI":"10.1126\/scisignal.aaf7478"},{"issue":"2","key":"12485_CR8","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.4238\/2015.May.4.11","volume":"14","author":"BL Xing","year":"2015","unstructured":"Xing BL et al (2015) Cumulative methylation alternations of gene promoters and protein markers for diagnosis of epithelial ovarian cancer. Genet Mol Res 14(2):4532\u20134540. https:\/\/doi.org\/10.4238\/2015.May.4.11","journal-title":"Genet Mol Res"},{"key":"12485_CR9","doi-asserted-by":"crossref","unstructured":"Cai LZ et al (2023) Unveiling the molecular structure and role of RBBP4\/7: implications for epigenetic regulation and cancer research. Front Mol Biosci 10 doi:ARTN 127661210.3389\/fmolb.2023.1276612","DOI":"10.3389\/fmolb.2023.1276612"},{"key":"12485_CR10","doi-asserted-by":"crossref","unstructured":"Peng G et al (2014) Genome-wide transcriptome profiling of homologous recombination DNA repair. Nat Commun 5 doi:ARTN 336110.1038\/ncomms4361","DOI":"10.1038\/ncomms4361"},{"issue":"5","key":"12485_CR11","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3892\/or.2012.1680","volume":"27","author":"HS Isaksson","year":"2012","unstructured":"Isaksson HS, Sorbe B, Nilsson TK (2012) Whole blood RNA expression profiles in ovarian cancer patients with or without residual tumors after primary cytoreductive surgery. Oncol Rep 27(5):1331\u20131335. https:\/\/doi.org\/10.3892\/or.2012.1680","journal-title":"Oncol Rep"},{"issue":"6","key":"12485_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3892\/ol.2020.12221","volume":"20","author":"OS Erdogan","year":"2020","unstructured":"Erdogan OS et al (2020) Genome-wide methylation profiles in monozygotic twins with discordance for ovarian carcinoma. Oncol Lett 20(6):357. https:\/\/doi.org\/10.3892\/ol.2020.12221","journal-title":"Oncol Lett"},{"issue":"215","key":"12485_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jama.2013.281053","volume":"36","author":"World Medical Association","year":"2014","unstructured":"WorldMedical Association (2014) [The Helsinki Declaration of the World Medical Association (WMA). Ethical principles of medical research involving human subjects]. Pol Merkur Lekarski 36(215):298\u2013301. https:\/\/doi.org\/10.1001\/jama.2013.281053","journal-title":"Pol Merkur Lekarski"},{"key":"12485_CR14","unstructured":"ZYMO RESEARCH https:\/\/files.zymoresearch.com\/protocols\/_d5310_onestep_qmethy_kit.pdf"},{"issue":"15","key":"12485_CR15","doi-asserted-by":"publisher","first-page":"167094","DOI":"10.1016\/j.jmb.2021.167094","volume":"433","author":"A Butera","year":"2021","unstructured":"Butera A, Melino G, Amelio I (2021) Epigenetic Drivers of Cancer. J Mol Biol 433(15):167094. https:\/\/doi.org\/10.1016\/j.jmb.2021.167094","journal-title":"J Mol Biol"},{"key":"12485_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43042-021-00185-6","volume":"22","author":"AM Nomair","year":"2021","unstructured":"Nomair AM et al (2021) SCGB3A1 gene DNA methylation status is associated with breast cancer in Egyptian female patients. Egypt J Med Hum Genet 22:1\u201312","journal-title":"Egypt J Med Hum Genet"},{"key":"12485_CR17","doi-asserted-by":"crossref","unstructured":"Oliver J et al (2022) Emerging noninvasive methylation biomarkers of cancer prognosis and drug response prediction. In: Seminars in cancer biology 83. Elsevier, pp157","DOI":"10.1016\/j.semcancer.2021.03.012"},{"key":"12485_CR18","doi-asserted-by":"crossref","unstructured":"Hussain S et al (2022) Role of epigenetics in carcinogenesis: recent advancements in anticancer therapy. In: Seminars in cancer biology. vol 83. Elsevier, p^pp 157","DOI":"10.1016\/j.semcancer.2021.06.023"},{"key":"12485_CR19","doi-asserted-by":"crossref","unstructured":"Rattanapan Y, Chareonsirisuthigul T (2021) Epigenetic events in ovarian Cancer. In: Ovarian Cancer-updates in tumour biology and therapeutics. IntechOpen","DOI":"10.5772\/intechopen.95472"},{"key":"12485_CR20","doi-asserted-by":"crossref","unstructured":"Tao L et al (2024) Epigenetic regulation in cancer therapy: From mechanisms to clinical advances. Medcomm-Oncol 3(1) doi:ARTN e5910.1002\/mog2.59","DOI":"10.1002\/mog2.59"},{"key":"12485_CR21","doi-asserted-by":"crossref","unstructured":"Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H (2019) Ovarian cancer in the world: epidemiology and risk factors. Int J women\u2019s health :287\u2013299","DOI":"10.2147\/IJWH.S197604"},{"issue":"13","key":"12485_CR22","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1056\/NEJMra1813254","volume":"380","author":"P Morice","year":"2019","unstructured":"Morice P, Gouy S, Leary A (2019) Mucinous ovarian carcinoma. N Engl J Med 380(13):1256\u20131266","journal-title":"N Engl J Med"},{"issue":"12","key":"12485_CR23","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.3390\/cancers12123730","volume":"12","author":"P Charkhchi","year":"2020","unstructured":"Charkhchi P et al (2020) CA125 and ovarian cancer: a comprehensive review. Cancers 12(12):3730","journal-title":"Cancers"},{"issue":"4","key":"12485_CR24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s12291-018-0786-2","volume":"33","author":"S Kumari","year":"2018","unstructured":"Kumari S (2018) Serum biomarker based algorithms in diagnosis of ovarian cancer: A review. Indian J Clin Biochem 33(4):382\u2013386","journal-title":"Indian J Clin Biochem"},{"issue":"6","key":"12485_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2020.12221","volume":"20","author":"OS Erdogan","year":"2020","unstructured":"Erdogan OS et al (2020) Genome\u2013wide methylation profiles in monozygotic twins with discordance for ovarian carcinoma. Oncol Lett 20(6):1\u20131","journal-title":"Oncol Lett"},{"issue":"1","key":"12485_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12885-023-10549-3","volume":"23","author":"SM Elsharkawi","year":"2023","unstructured":"Elsharkawi SM et al (2023) PCDH17 gene promoter methylation status in a cohort of Egyptian women with epithelial ovarian cancer. BMC Cancer 23(1):89","journal-title":"BMC Cancer"},{"issue":"12","key":"12485_CR27","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1002\/1878-0261.13108","volume":"15","author":"M Elazezy","year":"2021","unstructured":"Elazezy M et al (2021) BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer. Mol Oncol 15(12):3615\u20133625","journal-title":"Mol Oncol"},{"key":"12485_CR28","doi-asserted-by":"crossref","unstructured":"Terp SK, Stoico MP, Dybkaer K, Pedersen IS (2023) Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review. Clin Epigenetics 15(1) doi:ARTN 2410.1186\/s13148-023-01440-w","DOI":"10.1186\/s13148-023-01440-w"},{"key":"12485_CR29","doi-asserted-by":"crossref","unstructured":"Terp SK et al (2025) Genome-wide cfDNA methylation profiling reveals robust hypermethylation signatures in ovarian cancer. Cancers 17(12) doi:ARTN 202610.3390\/cancers17122026","DOI":"10.3390\/cancers17122026"},{"issue":"7","key":"12485_CR30","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1111\/cas.70078","volume":"116","author":"S Tsuchimochi","year":"2025","unstructured":"Tsuchimochi S et al (2025) Promoter Methylation in Ovarian Cancer: Clinical Relevance and a Novel Diagnostic Approach Using Fragment Analysis. Cancer Sci 116(7):1996\u20132007. https:\/\/doi.org\/10.1111\/cas.70078","journal-title":"Cancer Sci"},{"issue":"9","key":"12485_CR31","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41419-023-06149-5","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y et al (2023) Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion. Cell Death Dis 14(9):624","journal-title":"Cell Death Dis"},{"issue":"1","key":"12485_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12920-022-01413-7","volume":"15","author":"H Wang","year":"2022","unstructured":"Wang H, Lu X, Chen J (2022) Construction and experimental validation of an acetylation-related gene signature to evaluate the recurrence and immunotherapeutic response in early-stage lung adenocarcinoma. BMC Med Genom 15(1):254","journal-title":"BMC Med Genom"},{"issue":"10","key":"12485_CR33","doi-asserted-by":"publisher","first-page":"e1003295","DOI":"10.1371\/journal.pmed.1003295","volume":"17","author":"G Funston","year":"2020","unstructured":"Funston G et al (2020) The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study. PLoS Med 17(10):e1003295","journal-title":"PLoS Med"},{"issue":"3","key":"12485_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.33545\/pathol.2022.v5.i3a.472","volume":"5","author":"G Bilonia","year":"2022","unstructured":"Bilonia G, Mathur R, Singh S (2022) Comparative study of significance of serum human epididymis protein 4 (HE4) and carbohydrate antigen 125 (CA125) as an early tumour marker in female patients with ovarian cancer. Int J Clin Diagn Pathol 5(3):12\u201315. https:\/\/doi.org\/10.33545\/pathol.2022.v5.i3a.472","journal-title":"Int J Clin Diagn Pathol"},{"issue":"5","key":"12485_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12032-022-01679-y","volume":"39","author":"T Ebata","year":"2022","unstructured":"Ebata T et al (2022) DNA methylation marker to estimate ovarian cancer cell fraction. Med Oncol 39(5):78","journal-title":"Med Oncol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12485-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:19:00Z","timestamp":1785521940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12485-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12485"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12485-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study complies with ethical standards. The conformity approval of the Istanbul University Istanbul Faculty of Medicine Clinical Research Ethics Committee was granted to conduct the study in Istanbul University, Oncology Institute, in the Department of Basic Oncology, with the date 08.11.2019 and no 1305. All patients were informed about the study, and consent was granted within the scope of the cancer genetics polyclinic. Each individual signed individual consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was received for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u201cThe authors declare no conflict of interest.\u201d \u201cThe funders had no role in the study\u2019s design; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results\u201d.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1292"}}